Intelligence / Healthtech / Health Funding Register / NurExone Biologic Inc.
Fundingraised $450K21 Aug 2026
NurExone Biologic Inc.
21 Aug 2026: Raised $450K · Technion City, Haifa, L3. Recorded in the SEC Form D data sets.
- Filed
- 21 Aug 2026
- Location
- Technion City, Haifa, L3
- State
- Israel
- Industry
- Biotechnology
- Amount raised
- $450K
- Offering size
- $450K
- Revenue range
- Decline to Disclose
- Year of incorporation
- 2025
- Entity type
- Corporation
- Jurisdiction
- Ontario, Canada
- First sale
- 2026-08-20
- Securities
- Equity, Options
- Investors so far
- 2
- SEC CIK
- 0001995074
What this signal means
Companies buy in the months after they raise: new hires, new vendors, new markets.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
Reach them with AOS
Find the decision makers at NurExone Biologic Inc.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.
More from Israel
Health Funding Register
10 SeptCan-Fite BioPharma Ltd.raised $8.3M · Ramat Gan, L3Funding10 SeptPolyrizon Ltd.raised $4.0M · Raanana, L3Funding9 SeptBioLineRx Ltd.raised $3.8M · Modi'In, L3Funding4 SeptPluri Inc.raised $3.7M · Haifa, L3Funding19 AugIntercure Ltd.filed a raise · Hertzliya, L3Funding12 AugEntera Bio Ltd.raised $275M · Jerusalem, L3Funding
Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.